Gynaecomastia A Hidden Cause - Case Report

Abstract

When estrogens and androgens interact to stimulate breast tissue and inhibit it, the result is a feminized male breast known as gynecomastia, or the growth of fibroglandular tissue in the male breast. When it comes to males, physiological factors and certain medical disorders are more frequently the cause of gynecomastia.

Gynecomastia is identified by palpably thick and mobile subareolar tissue in the male breast. A secondary cause of hypertension or an adverse pharmacological reaction to an antihypertensive medication may be indicated by breast enlargement in men.

The secondary causes of hypertension linked to gynecomastia include hyperthyroidism, chronic renal failure, adrenal hyperplasia or tumors, amphetamine, cyclosporine, and anabolic drugs. Older medications linked to gynecomastia include methyldopa, spironolactone, and serpine; more frequently, calcium antagonists, angiotensin-converting enzyme inhibitors, and α1 blockers may also be connected to this discovery.Very little data has been found thus far to support the theory that angiotensin receptor blockers are the main cause of gynecomastia. Nonetheless, our research provides additional proof linking angiotensin receptor blocker Treatment aims to induce gynecomatia, which eliminates the underlying cause. This is mainly accomplished via complete excision and breast tissue biopsy.